Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Apr 23 2021

Apr 23, 2021 at 3:31 PM UTC

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated April 23, 2021, titled "Caplin Steriles gets USFDA approval for Prochlorperazine Edisylate Injection".

View Attachment